The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, ACADIA Pharmaceuticals's share price is $16.31.
ACADIA Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $4.42. Hence, ACADIA Pharmaceuticals's PS Ratio for today is 3.69.
Good Sign:
ACADIA Pharmaceuticals Inc stock PS Ratio (=3.74) is close to 10-year low of 3.74
The historical rank and industry rank for ACADIA Pharmaceuticals's PS Ratio or its related term are showing as below:
ACAD'
s PS Ratio Range Over the Past 10 Years
Min: 3.69 Med: 19.64 Max: 37040
Current: 3.71
During the past 13 years, ACADIA Pharmaceuticals's highest PS Ratio was 37040.00. The lowest was 3.69. And the median was 19.64.
ACAD's PS Ratio is ranked better than 72.86% of 991
companies
in the Biotechnology industry
Industry Median: 8.98
vs ACAD: 3.71
During the past 12 months, the average Revenue per Share Growth Rate of ACADIA Pharmaceuticals was 38.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 16.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 131.10% per year.
During the past 13 years, ACADIA Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 1109.20% per year. The lowest was -77.60% per year. And the median was -16.20% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ACADIA Pharmaceuticals's PS Ratio
For the Biotechnology subindustry, ACADIA Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACADIA Pharmaceuticals's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ACADIA Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where ACADIA Pharmaceuticals's PS Ratio falls into.
ACADIA Pharmaceuticals PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
ACADIA Pharmaceuticals's Share Price of today is $16.31. ACADIA Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
ACADIA Pharmaceuticals (NAS:ACAD) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
ACADIA Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of ACADIA Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ACADIA Pharmaceuticals (ACADIA Pharmaceuticals) Business Description
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACAD has been successfully added to your 